Other studies have suggested that a small molecule inhibitor of SREBP1, SI-1, could be a promising treatment for advanced hepatocellular carcinoma and that betulin enhances the antitumor effect of Sorafenib on hepatocellular carcinoma via modulating metabolism [57,58]. Here, SREBF1 is linked to hepatocellular carcinoma.